TABLE 2.
Characteristic | Value (n = 54) |
---|---|
Linezolid medication | |
Medication days (d), median [IQR] | 10.00 (9.00, 11.00) |
Concomitant antibiotics, n (%) | 23 (42.59) |
Meropenem | 17 |
Piperacillin-tazobactam | 3 |
Cefoperazone-sulbactam | 2 |
Imipenem-cilastatin | 1 |